Details

Last Funding Type

Series A

Last Funding Money Raised

$6M

Industries

Artificial Intelligence,Computer Vision,Health Care,Health Diagnostics,Machine Learning,Medical,Medical Device

Founded date

Jan 1, 2011

Number Of Employee

101 - 250

Operating Status

Active

Legal Name

Sight Diagnostics Inc.

Sight Diagnostics is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient and accurate diagnostics. Developed over almost a decade of research, Sight’s technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics and computer science.

Sight’s first product, Parasight*, has diagnosed malaria in close to 1 million tests across 24 countries. Sight OLO, Sight’s latest FDA 510(k) cleared blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade Complete Blood Count results in minutes. Sight has growing offices in the UK, the US and Israel, and commercial footprint on 5 continents.

*Note: Parasight is not available for sale in the US and did not receive FDA clearance for use in the US.